The genomic action of calcitriol (1,25-dihydroxy-vitamin D3) is mediated through the interaction of the calcitriol receptor (VDR) with vitamin D response elements (VDREs). Although renal failure is associated with resistance to the action of calcitriol, the mechanism of this resistance is not well understood. Therefore, we used the electrophoretic mobility shift assay to compare the ability of VDRs from normal and renal failure rats to bind to the osteocalcin gene VDRE. 
Introduction
The calcitriol (1,25-dihydroxy-vitamin D3) receptor (VDR)' is a nuclear protein of the erbA superfamily that regulates gene expression in a ligand-dependent manner (1) . The hormonereceptor complex interacts with specific DNA sequences (vitamin D response elements, VDREs), generally located in the 5 flanking regions of target genes, and thus regulates the transcription of those genes. The resulting changes in protein expression are ultimately responsible for the biological activity of calcitriol (2, 3) . Renal failure is associated with resistance to the action of calcitriol. For example, absorption of intestinal calcium remained lower in uremic rats compared with normal rats receiving pharmacological doses of calcitriol (4) ; parathyroid hormone is elevated despite a normal plasma concentration of calcitriol in renal failure (5) ; and chronic replacement of calcitriol failed to normalize calcitriol metabolic clearance (6) and intestinal 24-hydroxylase activity in renal failure (7) . However, the underlying mechanisms are not well understood. We have shown previously that uremic ultrafiltrate inhibits the interaction of VDR with DNA-cellulose (8, 9) . Although the DNAcellulose binding characteristics of receptors may accurately predict their functional properties (10) (11) (12) , recent studies have indicated that the interaction of VDR with DNA-cellulose may not be as specific as previously predicted (13, 14) . Therefore, the role of the VDR-DNA interaction in calcitriol resistance is better evaluated using natural VDREs. In these experiments, we demonstrate that VDR extracted from rats with renal failure shows impaired binding to a VDRE. In addition, this effect is recapitulated by incubation of normal VDR with a uremic plasma ultrafiltrate. Furthermore, the uremic plasma ultrafiltrate impairs the ability of VDR to activate target genes in a transfection system.
Methods Preparation of HPLC-fractionated normal and uremic ultrafiltrates
Uremic plasma ultrafiltrates were obtained from chronic hemodialysis patients. Patients were dialyzed with 1.3 m2 Polysulfone membranes. The ultrafiltrates were collected at the beginning of dialysis from the effluent side of the Polysulfone membrane. Normal pooled plasma was treated identically. Ultrafiltrates were aliquoted into 2-ml fractions, and each 2-ml fraction was subjected to ultrafiltration through a Centrifreem filter (Amicon Division, W. R. Grace & Co., Danvers, MA). Both normal and uremic ultrafiltrates were fractionated by semipreparative HPLC on a RSil C18, 10-pim column (length 25 cm, inner diameter 10 mm) into 13 distinct fractions which were lyophilized as described previously (15) . Fractions (19) . The gels were dried and autoradiographed, and each VDR-osteocalcin VDRE complex was quantified by excising the portion of the gel corresponding to its location on the autoradiograph. The radioactivity in each excised gel was determined by liquid scintillation counting. The amount of radiolabeled probe associated with VDR that had been incubated with either normal or uremic ultrafiltrate was expressed as a percentage of control VDR incubated in a buffer solution without ultrafiltrate.
To confirm the specificity of VDR-VDRE complex, the following studies were performed. The cellular proteins were incubated for 20 min with: (a) 10 ng nonradiolabeled VDRE or 10 ng nonspecific DNA (from the chick /3 actin gene); (b) 1 and 9 lag of either rat anti-VDR monoclonal antibody 9A7 (20) [21] ) was labeled by a fill-in reaction and used as a probe in a series of EMSAs. The initial experiments were performed as described for the osteocalcin probe and used rat intestinal extracts, N-UF and U-UF, as indicated. In addition, in some studies the intestinal extract was preincubated for 20 min at room temperature with either the anti-VDR mAb or an antiretinoid X receptor (RXR) mAb (22) ( (30, 60 , and 100%) of N-UF or U-UF (or buffer). Incubations were performed at 15'C because the VDR was found to lose some DNA binding activity after incubation in buffer alone at room temperature for 1 h. Thereafter, these receptor preparations were added to EMSA incubations as described above. Since the 35-1l EMSA incubations required only 1-2 tl of ultrafiltrate-incubated VDR and RXRa, the concentration of N-UF or U-UF was diluted 17.5-35-fold during the EMSA incubations.
The following studies were performed to test whether the effect of U-UF on VDR was irreversible. E. coli-derived VDR was incubated for 1 h at 15C with 60% N-UF or U-UF (or buffer). The (23) . An identical transfection protocol was used in these experiments. The human VDR cDNA was expressed from the vector pCDM. The reporter plasmid was derived from pUTKAT3 (21) , and contained two copies of the sequence 5'-GATCCACTAGGTCAAGGAGGTCAT-GGATC ligated 5' to the basal thymidine kinase promoter driving expression of chloramphenicol acetyltransferase (CAT) (pTKD2AA). An internal control plasmid expressing human growth hormone (GH) from the basal thymidine kinase promoter (pTKGH) was used to control for transfection efficiency. Transfections included 4 tig of pTKD2AA, 10 ng of pCDMVDR, 1 I.g of pTKGH, and 6 ,g of pCDM as filler plasmid per 60-mm Petri dish. Cells were cultured with or without 100 nM calcitriol for 2 d after transfection. In certain experiments, N-UF or U-UF was added for the 2 d after transfection at a final concentration of up to 50%. Cell lysates were analyzed for CAT activity and media for human GH as described (23) . Fold CAT induction is defined as CAT/ human GH for cells cultured with calcitriol divided by CAT/human GH for cells cultured without calcitriol.
[3H]Calcitriol binding experiments were performed to test whether cell culture in the presence of U-UF altered expression of the recombinant VDR. JEG-3 cells were transfected with pCDMVDR and cultured for 2 d in the presence of 50% N-UF, 50% U-UF, or control media. Cell extracts were prepared and used in The effect of uremic ultrafiltrate on the binding of VDRs to the osteocalcin VDRE. The effect of uremic ultrafiltrate on the VDR-VDRE interaction is depicted in Fig. 2 . As shown in lanes 6-8, the normal ultrafiltrate, even up to 100%, did not impair the VDR-VDRE complex. However, uremic ultrafiltrate inhibited the interaction of the VDR with the osteocalcin VDRE in a dose-related manner (lanes 9-11). These data are quantified in Fig. 3 .
To determine whether this effect of uremic ultrafiltrate was due to a change in N,,, or Kd, EMSA incubations were performed with normal or uremic ultrafiltrate and increasing doses of VDRE (0.125-4 nM), and the appropriate bands were then subjected to Scatchard analysis. As depicted in Figs. 4 Studies with radiolabeled recombinant VDR were performed to exclude the possibility that the effect of uremic ultrafiltrate on DNA binding was due to proteolytic degradation of the VDR. 35S-labeled VDR was incubated with 100% N-UF, 100% U-UF, or buffer alone for 1 h at room temperature and then analyzed by SDS-PAGE (Fig. 6) . The pattern of translation products was identical for all incubations and was identical to that of freshly translated 35S-labeled VDR. The major translation (Fig. 8) . Immunoblot studies of the VDR extracted from control and renal failure rats showed that they had identical rats with the osteopontin VDRE led to the formation of two protein-DNA complexes as analyzed by EMSA (Fig. 9, lane  2) . The addition of monoclonal antibodies to VDR (lane 3) or RXR (lane 5) indicated that the faster migrating complex (solid arrow) represents a VDR-RXR heterodimer on the DNA. The nature of the slower migrating complex is unknown. It was unaffected by the RXR antibody and thus presumably does not contain RXR. The intensity of this complex was modestly diminished by the anti-VDR antibody. Therefore, it might contain VDR in a conformation that is only partially accessible to the antibody-perhaps as a homodimer, for example. Alternatively, the modest effect of the anti-VDR monoclonal antibody could represent crossreactivity with another DNA binding protein. Since we find that recombinant VDR does not bind to this DNA as a homodimer (see below), we favor the latter interpretation. beled osteopontin VDRE and Lane 1 2 3 4 5 6 analyzed by EMSA. Lane Fig. 10 shows that incubation of the intestinal extract with U-UF resulted in decreased VDR-RXR binding to the probe (lanes 7-9), whereas N-UF was without effect (lanes 4-6). These results are similar to those obtained with the osteocalcin VDRE. In addition, it should be noted that U-UF also inhibited formation of the unidentified slower migrating protein-DNA complex.
The above results could indicate an effect of U-UF on VDR, RXR, or both. To address this we performed studies with recombinant VDR and RXRa purified from E. coli. Fig. 11 illustrates that neither recombinant protein alone formed a detectable complex with the osteopontin VDRE probe (lanes 2 and 3) . However, addition of VDR plus RXRa resulted in the formation of a heterodimer complex with the probe (lane 4), consistent with the results of Fig. 9 using intestinal extracts. This VDR-RXR-VDRE complex was quenched by the addition of 100-fold excess of nonradiolabeled VDRE (lane 5), but not by the addition of 100-fold excess of actin DNA (lane 6), as expected for a specific protein-DNA complex. Recombinant VDR or RXRa was separately preincubated with N-UF or U-UF for 1 h and then used in an EMSA with the other receptor and the osteopontin VDRE as the probe. Preincubation of VDR with U-UF inhibited formation of the VDR-RXR-DNA complex in a dose-dependent manner (Fig.  11, lanes 8 and 9) , whereas N-UF had no effect even at 100% (lane 7). In contrast, preincubation of RXR with even 100% U-UF failed to impair formation of the VDR-RXR-VDRE complex (lane 11). These results indicate that the ability of U-UF to impair the formation of a VDR-RXR-DNA complex is due to an effect on the VDR.
Experiments were performed to assess whether the effect of U-UF on the VDR is irreversible. After a 1-h incubation of E. coli-derived VDR with 60% U-UF or N-UF, the mixtures were diluted 40-fold in iced EMSA binding buffer and then concentrated back to their original volumes by ultrafiltration through a Centricon-30. Since the U-UF and N-UF were originally prepared by ultrafiltration through a membrane with a molecular weight cutoff of -10,000, it can be assumed that the uremic toxin(s) in U-UF will readily pass through a Centricon-30 (30,000 molecular weight cutoff). After concentration through the Centricon-30, the VDRs were used in an EMSA with the osteopontin VDRE as the probe. The final concentration of U-UF or N-UF in the EMSA incubation was -0.4%. As seen in Fig. 12 lanes 5-7 used 2.5-fold more receptor than lanes 2-4 in order to enhance the sensitivity for detecting a VDR-RXR-DNA complex in lane 7. These studies are consistent with the notion that U-UF irreversibly modifies the VDR and therefore does not have to be present during the DNA binding reaction to inhibit the VDR-VDRE interaction.
The effect of uremic ultrafiltrate on the calcitriol-dependent expression of CAT activity in transfected JEG-3 cells. JEG-3 cells were transiently transfected with a VDR expression plasmid, a VDRE-containing CAT reporter plasmid, and an internal control plasmid expressing human GH. In the absence of transfected VDR, calcitriol induction of CAT was < 1.5-fold (data not shown). However, after cotransfection with the expression vector pCDMVDR, calcitriol induced CAT activity 23-fold (Fig. 13, Control) . Addition of 50% N-UF did not alter the CAT induction, whereas 33 and 50% U-UF inhibited calcitrioldependent CAT activity in a dose-dependent manner (Fig. 13) . Furthermore, this effect of U-UF was on the calcitriol-induced activity, not the basal CAT activity. In addition, U-UF had no effect on human GH expression (data not shown).
[ Fold CAT Induction (+VitD/-VitD) 30 Figure 13 . The effect of uremic ultrafiltrate on the expression of calcitriol-induced CAT activity in transfected JEG-3 cells. JEG-3 cells were transfected with a VDR expression vector, a CAT reporter plasmid driven by a calcitriol responsive promoter, and a human GH-expressing reporter as an internal control. Cells were incubated with 0, 33, or 50% N-UF or U-UF, in each case with or without 100 nM calcitriol, for 48 h. Fold CAT induction is defined as CAT/human GH for cells cultured with calcitriol divided by CAT/human GH for cells cultured without calcitriol. Results are the mean±SE for four independent transfections, except for 33% U-UF, which represents two independent transfections. those of Fig. 13 indicate that U-UF impairs the ability of calcitriol to induce the expression of target genes, but that this effect is not due to a reduction in the expression of VDRs.
Overall the data are consistent with the hypothesis that U-UF impairs VDR-DNA interactions within the cell, thereby limiting the calcitriol response.
Discussion
We have demonstrated previously that uremic ultrafiltrate inhibited the interaction of VDR with DNA-cellulose (8, 9) . Although the binding of VDR to DNA-cellulose may not directly measure the interaction of VDR with biologically relevant DNA sequences, several studies have demonstrated that the binding properties of VDR to DNA-cellulose accurately reflect the functional characteristics of the VDR (10) (11) (12) . However, since the binding to nonspecific DNA may be mechanistically distinct from that to specific VDREs, serious consideration must be given to the possibility that measurement of nonspecific DNA binding may not always be an accurate surrogate for specific DNA binding. Since the VDREs of the osteocalcin and osteopontin genes have been well characterized (21, 26, 27) , it is now possible to perform VDR-DNA binding studies with these specific genes sequences. Thus, the present studies were undertaken to characterize the effect of uremic toxins on the binding properties of the VDR to the osteocalcin and osteopontin VDREs.
In our previous studies (9) we showed that VDR incubated for 3 h with uremic ultrafiltrate eluted from a DNA-cellulose column as a single peak at a lower ionic strength than the receptor incubated with normal ultrafiltrate. The A recent study (28) has indicated that enhanced proteolytic degradation of the VDR during its preparation (without protease inhibitors) may occur in renal failure. Protease inhibitors (Trasylol and soybean trypsin inhibitor) were used throughout the preparation of intestinal receptors in the present study. Although addition of soybean trypsin inhibitor in receptor preparations significantly stabilized the intestinal VDR (16), it is possible that the receptors isolated from renal failure rats could be defective forms artificially produced by the action of an endogenous protease during preparation, resulting in a receptor deficient in DNA binding (29, 30) . However, this seems unlikely as a sucrose gradient analysis of the receptor from control and renal failure rats revealed identical sedimentation coefficients of 3.3 S (9) and the Western blot study showed that the VDRs of renal failure and control animals had identical molecular weights. Most important, the DNA binding defect of VDR extracted from renal failure rats is reproduced by the incubation of normal VDR with uremic ultrafiltrate, and SDS-PAGE analysis demonstrates that this effect of uremic ultrafiltrate is not accounted for by proteolytic activity (Fig. 6) .
The DNA binding domain of the VDR has two zinc fingers which contain eight essential cysteine residues (1) . This region is sensitive to chemical modification by pyridoxal 5- [32] [33] [34] . This modification could also account for the pyridoxal phosphate-induced inhibition of the interaction of VDR with DNA-cellulose (19) and with the osteocalcin (Fig. 2) Recent studies have demonstrated that RXR and perhaps other nuclear factors are required for high affinity VDR binding to many (13, 14, 35 ), but perhaps not all (36), VDREs. Indeed, in these studies we find that the endogenous VDR binds to the osteopontin VDRE as a heterodimer with RXR, and that E. coli-derived VDR and RXR only bind to this VDRE as a heterodimer. Therefore, it is worth considering whether an effect of uremic toxins on RXR could underlie our results. However, deficient production of RXR in renal failure is not a likely explanation for our data since the in vitro incubation of normal receptors with uremic ultrafiltrate recapitulates the defect seen with VDR extracted from renal failure rats. Furthermore, the use of E. coli-derived VDR and RXR allowed us to demonstrate that the inhibitory effect of U-UF is due to an interaction of U-UF with VDR, not RXR. This result is important for two reasons. First, RXR is a heterodimerization partner for thyroid hormone, retinoic acid, and other receptors (37) in addition to VDRs. Had RXR been the target for U-UF one would predict that this effect might indirectly impair gene regulation by numerous receptors in renal failure. Second, it indicates that the effect of U-UF on VDR-DNA binding cannot be generalized to all nuclear receptors. Thus, there is some specificity to this toxic effect of U-UF. The exact reason for this specificity is unknown and must await chemical identification of the toxic substance(s).
These studies were initiated in an attempt to explain the calcitriol resistance associated with renal failure. An important question is whether the ability of U-UF to impair VDR-DNA interactions in EMSAs has relevance to the actions of calcitriol within the cell. To address this we established a transient transfection model system. This model allowed us to show that incubation of cells with media containing U-UF does indeed impair the ability of calcitriol to induce the expression of a target gene. This effect could not be accounted for by impaired VDR expression, and U-UF does not impair calcitriol-VDR binding (38) . Thus, our results are consistent with the hypotheses that U-UF contains a toxin(s) that interacts with the VDR to impair its DNA binding within cells and that this results in a diminished calcitriol response in renal failure. This transfection system should be a valuable model to study this process, especially since whole animal studies are exceedingly complex and difficult to interpret. For example, some investigators have found that renal failure is associated with a decreased number of VDRs (39, 40) , which obviously could lead to calcitriol resistance. However, the decreased number of VDRs in renal failure could itself be taken as evidence in support of the decreased DNA binding mechanism. This is because calcitriol has been found to induce VDR expression (41) . Although the mechanism of this effect is not clear (41, 42) , if it is VDR mediated then interaction of the uremic toxin(s) with VDRs could explain the decreased VDR expression in renal failure. VDR expression is not inhibited by U-UF in our model system presumably because the VDR cDNA is expressed from a cytomegalovirus promoter that itself is not calcitriol responsive.
In summary, the VDR from rats with renal failure showed decreased binding to VDREs compared with the VDR from normal rats. A similar inhibitory effect was found when a uremic ultrafiltrate was incubated with normal endogenous or recombinant VDRs. This effect was due to an interaction of U-UF with the VDR, not RXR. Furthermore, U-UF impaired the ability of calcitriol-VDR complexes to induce expression from a target gene in a transfection system. Taken together, the results suggest that impaired VDR binding to VDREs could at least in part underlie the end-organ resistance to calcitriol in renal failure.
